SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-004398
Filing Date
2013-08-13
Accepted
2013-08-13 08:19:35
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q JUNE 30, 2013 tbuff_10q.htm 10-Q 676367
2 CERTIFICATION tbuff_ex311.htm EX-31.1 12120
3 CERTIFICATION tbuff_ex312.htm EX-31.2 11936
4 CERTIFICATION tbuff_ex321.htm EX-32.1 6609
5 CERTIFICATION tbuff_ex322.htm EX-32.2 6395
  Complete submission text file 0001354488-13-004398.txt   5004242

Data Files

Seq Description Document Type Size
6 tbuff-20130630.xml EX-101.INS 441219
7 tbuff-20130630_cal.xml EX-101.CAL 50576
8 tbuff-20130630_def.xml EX-101.DEF 65923
9 tbuff-20130630_lab.xml EX-101.LAB 227812
10 tbuff-20130630_pre.xml EX-101.PRE 166115
11 tbuff-20130630.xsd EX-101.SCH 37518
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 131031321
SIC: 2834 Pharmaceutical Preparations